Testing effectiveness (Phase 2)Study completedNCT01010646
What this trial is testing
Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4
Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 84